Jessica Lee

18PUBLICATIONS

198CO-AUTHORS

Medical infection agents (incl. prions)Molecular targetsPredictive and prognostic markersCancer geneticsLiquid biopsies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|May 14, 2026

Genomics of <i>MTAP</i> Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling Platforms.

|Mar 23, 2026

The Pan-Tumor Landscape of Gene Amplifications and Copy Number Amplification Ratio for Established and Emerging Clinical Targets.

Jessica K Lee, Julia C F Quintanilha, Kuei-Ting Chen

|Dec 29, 2025

C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.

Julia Yemelyanenko, Jinhyuk Bhin, Eline van der Burg

|Sep 16, 2025

Fibroblast Growth Factor Receptor 3 Alteration Status and Outcomes on Immune Checkpoint Inhibitors in Patients With Metastatic Urothelial Carcinoma.

Shilpa Gupta, Jessica K Lee, Jerry Mitchell

|Apr 10, 2025

Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study.

Takao Fujisawa, Yoshiaki Nakamura, Hideaki Bando

|Oct 29, 2024

Clinical value of comprehensive genomic profiling on clinical trial enrollment for patients with advanced solid tumors.

Richard S P Huang, Jessica K Lee, Katherine T Lofgren

Pageof 3

Frequent Collaborators

Alexa B Schrock

Russell W Madison

Geoffrey R Oxnard

Richard S P Huang

Hanna Tukachinsky

Jeffrey S Ross

Brennan Decker

Julia Yemelyanenko

Sjoerd Klarenbeek

Siraj M Ali

Frequent Collaborators

Alexa B Schrock

Russell W Madison

Geoffrey R Oxnard

Richard S P Huang